SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosid who wrote (1716)3/6/2000 9:33:00 PM
From: jelrod3  Read Replies (1) of 1754
 
Pretty good call... daytraders and/or buyers boosted the price in pre-market trading, and as the day wore on, pulled the plug and sold.

Now, with the ITC announcement out, what do you think will happen tomorrow? And beyond tomorrow?

I have been looking at the whole "laser vision correction" industry. Am I missing something, or is it true that the real money will be made by the laser vision correction centers, like LCAV and LVCI, who will offer this "soon to be a commodity product" to the public at falling prices?

Looks like some 160 million people are afflicted with nearsightedness/farsightedness, and that about 60 million people can afford the procedure in the $1000 to $3000 range for both eyes. So far, about 1.2 to 2.0 million have had the procedure, so the market is far from being penetrated.

Admittedly, more lasers will be built and sold, and more license fees paid to companies like VISX, but WHO is really going to make the money profit margin wise? The service providers, or the laser makers?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext